Enwave Corporation Stock
€0.24
Your prediction
Enwave Corporation Stock
Pros and Cons of Enwave Corporation in the next few years
Pros
Cons
Performance of Enwave Corporation vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Enwave Corporation | -4.880% | 1.667% | 22.613% | 47.879% | 63.758% | -48.360% | -51.200% |
Resverlogix Corp | -11.630% | -7.317% | -22.449% | -38.710% | -29.630% | -89.385% | -95.476% |
Xenon Pharmaceuticals Inc. | -1.440% | -2.113% | -0.714% | -17.751% | -24.457% | -11.465% | - |
Fennec Pharmaceuticals Inc. | -2.220% | -2.222% | -8.333% | 8.197% | 12.821% | 28.155% | -18.012% |
News

EnWave Signs License Amendment with Procescir S.A. de C.V. to Expand Product Portfolio; Sells Auxiliary REV-related Equipment
Vancouver, B.C., June 11th, 2025 / EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") announced today that it has signed an amendment ( the “Amendment”) to the

EnWave Reports 2025 Second Quarter Consolidated Interim Financial Results
Vancouver, B.C., May 22nd, 2025. EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") today reported the Company’s consolidated interim financial results for the second

EnWave Signs License Amendment with Creations Foods to Expand License to Include Pet Treat Applications
Vancouver, B.C., May 20th, 2025, EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") announced today that it has signed an amendment ( the “Amendment”) regarding the